Skip to Content

Testosterone Pellets for Subcutaneous Implantation

Last Updated: April 22, 2020
Status: Current

Products Affected - Description
    • Testopel pellet, Endo Pharmaceuticals, 75 mg, for subcutaneous implantation 10 count, NDC 66887-0004-10
    • Testopel pellet, Endo Pharmaceuticals, 75 mg, for subcutaneous implantation 100 count, NDC 66887-0004-20
Reason for the Shortage
    • Endo Pharmaceuticals did not provide a reason for the shortage.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Endo Pharmaceuticals has Testopel pellets for subcutaneous implantation on back order and the company cannot estimate a release date.

Updated

Updated April 22, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created March 13, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide